The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 306 participants.
Also called NCT07359599
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose supportive care
- Phase
- Phase 4
- Enrolled
- 306 participants
- Sponsor
- Registry
-
NCT07359599 -
2025-522936-14-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Belgium
- Registry status
- Recruiting
Technical summary
Registry record NCT07359599. Randomized; quadruple masking; primary purpose supportive care. Start 2026-01-27 (actual); primary completion 2028-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension
- Acronym
- IRON-PH
- Condition
- Pulmonary Hypertension
- Condition
- Iron Deficiency
- Intervention (Drug)
- Ferric Carboxymaltose (FCM)
- Intervention (Drug)
- Sodium Chloride (NaCl) 0.9 %
- Lead sponsor
- Ziekenhuis Oost-Limburg
- Collaborator
- Federal Knowledge Centre (KCE)
Record details
- Record id
cardio:ct-nct07359599- Content hash
e2d08c6edbeda138331646872ccfd54f9a7e90e94d605bea025836f8067d9aa6